These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 38685044)
1. Therapeutic efficacy of generic artemether-lumefantrine in the treatment of uncomplicated malaria in Ghana: assessing anti-malarial efficacy amidst pharmacogenetic variations. Thomford NE; Kellermann T; Biney RP; Dixon C; Nyarko SB; Ateko RO; Ekor M; Kyei GB Malar J; 2024 Apr; 23(1):125. PubMed ID: 38685044 [TBL] [Abstract][Full Text] [Related]
2. Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women. Mutagonda RF; Kamuhabwa AAR; Minzi OMS; Massawe SN; Asghar M; Homann MV; Färnert A; Aklillu E Malar J; 2017 Jul; 16(1):267. PubMed ID: 28673292 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea. Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India. Bharti PK; Shukla MM; Ringwald P; Krishna S; Singh PP; Yadav A; Mishra S; Gahlot U; Malaiya JP; Kumar A; Prasad S; Baghel P; Singh M; Vadadi J; Singh MP; Bustos MD; Ortega LI; Christophel EM; Kashyotia SS; Sonal GS; Singh N Malar J; 2016 Oct; 15(1):498. PubMed ID: 27737665 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia. Hamainza B; Masaninga F; Moonga H; Mwenda M; Chanda-kapata P; Chalwe V; Chanda E; Kamuliwo M; Babaniyi OA Malar J; 2014 Nov; 13():430. PubMed ID: 25403945 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania. Hietala SF; Mårtensson A; Ngasala B; Dahlström S; Lindegårdh N; Annerberg A; Premji Z; Färnert A; Gil P; Björkman A; Ashton M Antimicrob Agents Chemother; 2010 Nov; 54(11):4780-8. PubMed ID: 20713675 [TBL] [Abstract][Full Text] [Related]
7. Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania. Joseph D; Kabanywanyi AM; Hulser R; Premji Z; Minzi OM; Mugittu K Malar J; 2013 Feb; 12():60. PubMed ID: 23399782 [TBL] [Abstract][Full Text] [Related]
8. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy. McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453 [TBL] [Abstract][Full Text] [Related]
9. Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy. Maganda BA; Minzi OM; Kamuhabwa AA; Ngasala B; Sasi PG Malar J; 2014 May; 13():205. PubMed ID: 24885714 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. Dama S; Niangaly H; Djimde M; Sagara I; Guindo CO; Zeguime A; Dara A; Djimde AA; Doumbo OK Malar J; 2018 Oct; 17(1):347. PubMed ID: 30290808 [TBL] [Abstract][Full Text] [Related]
11. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. West African Network for Clinical Trials of Antimalarial Drugs (WANECAM) Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy and safety of artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria treatment in Metehara, Central-east Ethiopia. Tesfaye M; Assefa A; Hailgiorgis H; Gidey B; Mohammed H; Tollera G; Tasew G; Assefa G; Bekele W; Mamo H Malar J; 2024 Jun; 23(1):184. PubMed ID: 38867217 [TBL] [Abstract][Full Text] [Related]
13. Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and resistance markers. Oyebola KM; Ligali FC; Owoloye AJ; Aina OO; Alo YM; Erinwusi B; Olufemi MJ; Salako BL Malar J; 2024 Aug; 23(1):261. PubMed ID: 39210367 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015-2017. Abuaku B; Duah-Quashie NO; Quaye L; Matrevi SA; Quashie N; Gyasi A; Owusu-Antwi F; Malm K; Koram K Malar J; 2019 Jun; 18(1):206. PubMed ID: 31234874 [TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria. Tchaparian E; Sambol NC; Arinaitwe E; McCormack SA; Bigira V; Wanzira H; Muhindo M; Creek DJ; Sukumar N; Blessborn D; Tappero JW; Kakuru A; Bergqvist Y; Aweeka FT; Parikh S J Infect Dis; 2016 Oct; 214(8):1243-51. PubMed ID: 27471317 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of artemether-lumefantrine for treating uncomplicated malaria in low- and high-transmission areas of Ghana. Mawuli MA; Amoah LE; Cui L; Quashie NB; Afrane YA Malar J; 2024 Feb; 23(1):40. PubMed ID: 38317164 [TBL] [Abstract][Full Text] [Related]
17. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM; Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine]. Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria. Djimdé AA; Tekete M; Abdulla S; Lyimo J; Bassat Q; Mandomando I; Lefèvre G; Borrmann S; Antimicrob Agents Chemother; 2011 Sep; 55(9):3994-9. PubMed ID: 21670177 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study. Vaughan-Williams CH; Raman J; Raswiswi E; Immelman E; Reichel H; Gate K; Knight S Malar J; 2012 Dec; 11():434. PubMed ID: 23272998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]